IPHA

Innate Pharma S.A. ADS

1.79

USD

IPHA Earnings Reports

Positive Surprise Ratio

IPHA beat 0 of 1 last estimates.

Next Report

Date of Next Report

Mar 26, 2026

Estimate for Q4 25 (Revenue/ EPS)

$2.17M

-$0.12

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Innate Pharma S.A. ADS earnings per share and revenue

On Nov 13, 2025, IPHA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.12 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.98 million, with a --% difference. The market reacted with a -5.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 2.17 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Innate Pharma S.A. ADS's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Innate Pharma S.A. ADS reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Innate Pharma S.A. ADS's Q3 2025 earnings?

The stock price moved down -5.21%, changed from $1.92 before the earnings release to $1.82 the day after.

When is Innate Pharma S.A. ADS expected to report next?

The next earning report is scheduled for Mar 26, 2026.

What are the forecasts for Innate Pharma S.A. ADS's next earnings report?

Based on 2 analysts, Innate Pharma S.A. ADS is expected to report EPS of -$0.12 and revenue of $2.17M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.